CareMax (CMAX) Tops Q3 EPS by 5c

CareMax (NASDAQ: CMAX) reported Q3 EPS of ($0.03), $0.05 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $104.6 million versus the consensus estimate of $108.29 million.

For earnings history and earnings-related data on CareMax (CMAX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c